Apathy in Dementia
10
4
4
1
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
20.0%
2 terminated out of 10 trials
33.3%
-53.2% vs benchmark
10%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Robotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)
rTMS for Apathy Clinical Trial
The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD
SENS'REM - SENSoriality and Multi-Sensory Emotional Reminiscences: a Pilot Study
A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
TMS as a Treatment for Apathy in Alzheimer's Disease
Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders
Bupropion for the Treatment of Apathy in Alzheimer's Dementia